Anzeige
Mehr »
Login
Dienstag, 22.10.2024 Börsentäglich über 12.000 News von 675 internationalen Medien
Endlich!!! Gold-Aktien explodieren! Jetzt die Chance auf riesige Gewinne nutzen – mit dieser Aktie!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
GlobeNewswire (Europe)
825 Leser
Artikel bewerten:
(2)

JDE Peet's N.V.: JDE Peet's provides an update on its strategic roadmap and shares preliminary results for FY 22 at its strategic update meeting

PRESS RELEASE

Amsterdam, 24 January 2023


Key Highlights

  • JDE Peet's has made significant progress onits growth andpurpose-led strategy that was introduced in March 2021, and which supported a strong set of quality results since the companyentered the public market
  • The company has successfully accelerated growth in the US and in emerging markets, while strengthening capabilities and competitiveness in Digital Commerce and Single-Serve appliances
  • JDE Peet's' ESG performance and ambitions substantially increased in 2022. The company has defined the roadmap of initiatives that will enable a new commitment to net-zero, and built an integrated new carbon accounting platformto track and accelerate the delivery of its ESG objectives
  • The company announced the launch of a new, fully compostable coffee capsule in 2023, which allows for an uncompromising high-quality in-cup experience
  • JDE Peet'sconfirmedFY 22results to be in line with its outlook, providedits outlook for FY 23 and reiterated its medium- to long-term targets

JDE Peet's (EURONEXT: JDEP), the world's leading pure-play coffee and tea company by revenue, is hosting its Strategic Update Meeting for institutional investors and analysts in Amsterdam today. During this event, the company provided, among other things, an update on its achievements and progress versus its strategic roadmap, a selection of preliminary financial results for FY 22 as well as its outlook for 2023.

"I am very pleased with the progress we have made since we introduced our updated strategy two years ago," said Fabien Simon, CEO of JDE Peet's. "In spite of the challenging macro-economic environment, we are delivering on our commitments to build astronger,more productive, and more inclusive enterprise. Wekept high-quality standards for our consumers and customers,meaningfully reinvested in core assets,rebuilt employeepride and engagement, transformed from a laggard to a leader in ESG, while resuming cost competitiveness and achieving our financial commitments. Strengthening our fundamentals, our brands and our innovation capabilitieselevates our growth trajectoryand our ability to create a sustaininglong-term shareholder return and societal value."

Launch of a new,compostable coffee capsule to accelerate the sustainability agenda
The company will launch a fully compostable capsule in 2023, which will contribute to a circular economy. This new-to-the-world technology allows for a high-quality in-cup experience that was not achievable in existing compostable alternatives to date. This innovation will be introduced in selected markets throughout 2023 under L'OR, the global leading grocery brand in espresso capsules.

ESG performance & ambitions substantially increased in 2022 and a company-wide carbon accounting system has been implemented to track and support a net-zero future
In line with the company's purpose to unleash the possibilities of coffee and tea to create a better future, JDE Peet's has made significant progress on its sustainability agenda over the last two years. In addition to the reduction of its scope 1 & 2 green-house-gases by 17% since 2020, one of the key achievements in 2022 was the increase in responsibly sourced coffee from 30% in 2021 to 77%. In 2023, JDE Peet's will submit its stronger and new SBTi ambition to net-zero.

PreliminaryFY 22 financial results1
At the occasion of its Strategic Update Meeting, JDE Peet's confirms its 2022 outlook and shares the following preliminary, unaudited results related to FY 22:

  • Sales increased by 16.4%, driven by organic growth of 11.3%
  • Gross profit increased by 3.3%
  • SG&A increased by 10.6%, driven by working-media and other growth-related investments
  • Adj. EBIT decreased by 5.9%, and organically by -9.3%, as SG&A increased
  • Underlying EPS increased to EUR 1.91
  • Free cash flow of more than EUR 1.3 bn with a net leverage of 2.65x

The company will publish its FY 22 financial statements as scheduled on 22 February 2023, which may slightly deviate from the preliminary results set out in this release.

Outlook FY 2023
The company shared the following outlook for FY 23:

  • Organic sales growth at the high end of its medium-term range of 3 - 5%
  • Low single-digit organic adjusted EBIT growth, with a moderate increase in SG&A
  • A stable dividend

Medium- to Long-Term Targetsreiterated
For the medium- to long-term, JDE Peet's continues to target organic sales growth of 3 to 5% and mid-single digit organic adjusted EBIT growth, a free cash flow conversion of approximately 70% and stable to increasing dividends over time.

Additional information
The presentation slides of the event can be found hereand a video replay of the event, including synchronised slides, will be made available on the same webpagethe next day.

1This press release contains certain non-IFRS financial measures and ratios, which are not recognised measures of financial performance or liquidity under IFRS. For a reconciliation of these non-IFRS financial measures to the most directly comparable IFRS financial measures, see page 7 of the H1 22 Earnings Release.Organic sales and organic adjusted EBIT are adjusted for new business ventures.

# # #

Forward-looking Statements
These materials contain forward-looking statements as defined in the United States Private Securities Litigation Reform Act of 1995 concerning the financial condition, results of operations and businesses of the Group. These forward-looking statements and other statements contained in these materials regarding matters that are not historical facts and involve predictions. No assurance can be given that such future results will be achieved. Actual events or results may differ materially as a result of risks and uncertainties facing the Group. Such risks and uncertainties could cause actual results to vary materially from the future results indicated, expressed or implied in such forward-looking statements. There are a number of factors that could affect the Group's future operations and could cause those results to differ materially from those expressed in the forward-looking statements including (without limitation): (a) competitive pressures and changes in consumer trends and preferences as well as consumer perceptions of its brands; (b) fluctuations in the cost of green coffee, including premium Arabica coffee beans, tea or other commodities, and its ability to secure an adequate supply of quality or sustainable coffee and tea; (c) global and regional economic and financial conditions, as well as political and business conditions or other developments; (d) interruption in the Group's manufacturing and distribution facilities; (e) its ability to successfully innovate, develop and launch new products and product extensions and on effectively marketing its existing products; (f) actual or alleged non-compliance with applicable laws or regulations and any legal claims or government investigations in respect of the Group's businesses; (g) difficulties associated with successfully completing acquisitions and integrating acquired businesses; (h) the loss of senior management and other key personnel; and (i) changes in applicable environmental laws or regulations. The forward-looking statements contained in these materials speak only as of the date of these materials. The Group is not under any obligation to (and expressly disclaim any such obligation to) revise or update any forward-looking statements to reflect events or circumstances after the date of these materials or to reflect the occurrence of unanticipated events. The Group cannot give any assurance that forward-looking statements will prove correct and investors are cautioned not to place undue reliance on any forward-looking statements. Further details of potential risks and uncertainties affecting the Group are described in the Company's public filings with the Netherlands Authority for the Financial Markets (StichtingAutoriteitFinanciëleMarkten) and other disclosures.

Market Abuse Regulation
This press release contains information within the meaning of Article 7(1) of the EU Market Abuse Regulation.

Enquiries

Media
Khaled Rabbani
+31 20 558 1753
Media@JDEPeets.com

Investors & Analysts
Robin Jansen
+31 20 55 81212
IR@JDEPeets.com

About JDE Peet's

JDE Peet's is the world's leading pure-play coffee and tea company, serving approximately 4,500 cups of coffee or tea per second. JDE Peet's unleashes the possibilities of coffee and tea in more than 100 markets, with a portfolio of over 50 brands including L'OR, Peet's, Jacobs, Senseo, Tassimo, Douwe Egberts, OldTown, Super, Pickwick and Moccona. In 2021, JDE Peet's generated total sales of EUR 7 billion and employed a global workforce of more than 19,000 employees. Read more about our journey towards a coffee and tea for every cup at www.jdepeets.com.

Attachment

  • jde-peets-provides-an-update-on-its-strategic-roadmap-and-shares-preliminary-results-for-FY22-at-its-strategic-update-meeting (https://ml-eu.globenewswire.com/Resource/Download/db9ff8c1-db61-417c-8673-c64455c05ece)

© 2023 GlobeNewswire (Europe)
Tenbagger-Chance mit der nächsten BioNTech

Erinnern Sie sich, als Moderna und BioNTech von unbekannten Unternehmen zu globalen Marktführern wurden und frühzeitige Investoren reich belohnt haben?

Die Branche steht vor einem erneuten Innovationsschub – von bahnbrechenden Medikamenten bis hin zu revolutionären Therapien.

Warum sollten Sie dabei sein?

Sie sollten jetzt in Biotech-Aktien einsteigen, weil wir am Beginn einer neuen Ära der medizinischen Innovation stehen könnten! Gen- und Zelltherapien, personalisierte Medizin und bahnbrechende Technologien könnten das Gesundheitswesen revolutionieren – und die Aktienkurse in die Höhe schießen lassen.

Die nächste Erfolgsgeschichte im Biotechbereich warten nur darauf, entdeckt zu werden. Wer jetzt investiert, hat die Chance, von gigantischen Durchbrüchen und enormen Renditen zu profitieren. Warten Sie nicht, bis es zu spät ist - der nächste Biotech-Superstar könnte morgen schon durchstarten!

Verpassen Sie nicht diese Chance!

Fordern Sie sofort unseren brandneuen Biotech-Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien das riesige Potenzial haben, Ihren finanziellen Erfolg zu sichern. Dieser Report ist komplett kostenlos und zeigt Ihnen zukunftsträchtige Investments im Biotech-Sektor.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.